Sartorius AG (SOAGY)
66.63
+1.24
(+1.90%)
USD |
OTCM |
Oct 29, 16:00
Sartorius Enterprise Value : 17.15B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 17.15B |
| October 28, 2026 | 16.94B |
| October 27, 2026 | 16.84B |
| October 26, 2026 | 16.90B |
| October 23, 2026 | 16.57B |
| October 22, 2026 | 16.28B |
| October 21, 2026 | 15.79B |
| October 20, 2026 | 15.94B |
| October 19, 2026 | 15.69B |
| October 16, 2026 | 15.71B |
| October 15, 2026 | 15.80B |
| October 14, 2026 | 15.55B |
| October 13, 2026 | 15.37B |
| October 12, 2026 | 15.41B |
| October 09, 2026 | 15.58B |
| October 08, 2026 | 15.31B |
| October 07, 2026 | 15.69B |
| October 06, 2026 | 15.73B |
| October 05, 2026 | 15.39B |
| October 02, 2026 | 15.50B |
| October 01, 2026 | 15.35B |
| September 30, 2026 | 15.76B |
| September 29, 2026 | 15.94B |
| September 28, 2026 | 16.14B |
| September 25, 2026 | 15.94B |
| Date | Value |
|---|---|
| September 24, 2026 | 16.18B |
| September 23, 2026 | 15.67B |
| September 22, 2026 | 15.77B |
| September 21, 2026 | 15.68B |
| September 18, 2026 | 15.56B |
| September 17, 2026 | 15.55B |
| September 16, 2026 | 15.41B |
| September 15, 2026 | 15.21B |
| September 14, 2026 | 14.82B |
| September 11, 2026 | 15.02B |
| September 10, 2026 | 14.97B |
| September 09, 2026 | 15.19B |
| September 08, 2026 | 15.21B |
| September 04, 2026 | 15.22B |
| September 03, 2026 | 15.55B |
| September 02, 2026 | 15.56B |
| September 01, 2026 | 15.55B |
| August 31, 2026 | 15.67B |
| August 28, 2026 | 15.83B |
| August 27, 2026 | 15.89B |
| August 26, 2026 | 15.59B |
| August 25, 2026 | 15.64B |
| August 24, 2026 | 15.60B |
| August 21, 2026 | 15.82B |
| August 20, 2026 | 15.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Mesa Laboratories, Inc. | 875.07M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 3.920B |
| Agilent Technologies, Inc. | 53.27B |
| Bio-Rad Laboratories, Inc. | 10.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 109.41M |
| Revenue (Quarterly) | 1.066B |
| Total Expenses (Quarterly) | 989.68M |
| EPS Diluted (Quarterly) | 0.2203 |
| Gross Profit Margin (Quarterly) | 45.43% |
| Profit Margin (Quarterly) | 10.27% |
| Earnings Yield | 1.10% |
| Operating Earnings Yield | 3.30% |
| Normalized Earnings Yield | 1.281 |